85 related articles for article (PubMed ID: 19674356)
1. Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm.
Onouchi Z; Hamaoka K; Ozawa S; Sakata K; Kiyosawa N; Ito H
Pediatr Int; 2009 Aug; 51(4):448-52. PubMed ID: 19674356
[TBL] [Abstract][Full Text] [Related]
2. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
Williams K
J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
[TBL] [Abstract][Full Text] [Related]
3. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
Durongpisitkul K; Gururaj VJ; Park JM; Martin CF
Pediatrics; 1995 Dec; 96(6):1057-61. PubMed ID: 7491221
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
Qin L; Saumu MT; Wang H; Shi H; Hu X; Cheng P
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):348-50, 370. PubMed ID: 16201293
[TBL] [Abstract][Full Text] [Related]
5. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC; Aronoff SC
Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
[TBL] [Abstract][Full Text] [Related]
6. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
[TBL] [Abstract][Full Text] [Related]
7. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
Michihata N; Matsui H; Fushimi K; Yasunaga H
Clin Pediatr (Phila); 2015 Oct; 54(11):1076-80. PubMed ID: 25573948
[TBL] [Abstract][Full Text] [Related]
8. Intravenous gamma-globulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
[TBL] [Abstract][Full Text] [Related]
9. Kawasaki Disease.
Newburger JW; Takahashi M; Burns JC
J Am Coll Cardiol; 2016 Apr; 67(14):1738-49. PubMed ID: 27056781
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
11. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
De Rosa G; Pardeo M; Rigante D
Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular complications of Kawasaki disease: clinical cases].
Sica F; d'Amato E; Colapietra T; Romondia A
Pediatr Med Chir; 1995; 17(6):531-3. PubMed ID: 8668589
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Kawasaki disease in infants younger than six months of age.
Chang FY; Hwang B; Chen SJ; Lee PC; Meng CC; Lu JH
Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387
[TBL] [Abstract][Full Text] [Related]
14. Incomplete Kawaski disease: are we missing it?
Billoo AG; Lone SW; Siddiqui S; Atiq H
J Pak Med Assoc; 2009 Jan; 59(1):42-3. PubMed ID: 19213377
[TBL] [Abstract][Full Text] [Related]
15. Remission of autoimmune neutropenia after development of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Ichimura T; Kaneyasu H; Shimomura M; Wakabayashi-Takahara M; Nakamura K; Kobayashi M; Ohga S
Pediatr Int; 2015 Oct; 57(5):1012-4. PubMed ID: 26508185
[TBL] [Abstract][Full Text] [Related]
16. Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
Kim GB; Yu JJ; Yoon KL; Jeong SI; Song YH; Han JW; Hong YM; Joo CU
J Pediatr; 2017 May; 184():125-129.e1. PubMed ID: 28043685
[TBL] [Abstract][Full Text] [Related]
17. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
Chaker L; Drissa MA; Drissa H
Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024
[No Abstract] [Full Text] [Related]
18. Acute cholestasis: atypical onset of Kawasaki disease.
Valentini P; Ausili E; Schiavino A; Angelone DF; Focarelli B; De Rosa G; Ranno O
Dig Liver Dis; 2008 Jul; 40(7):582-4. PubMed ID: 18055284
[TBL] [Abstract][Full Text] [Related]
19. [Kawasaki disease: what you need to know].
Bajolle F; Laux D
Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
[TBL] [Abstract][Full Text] [Related]
20. Infections and Kawasaki disease: implications for coronary artery outcome.
Benseler SM; McCrindle BW; Silverman ED; Tyrrell PN; Wong J; Yeung RS
Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
